Documents
Access a comprehensive collection of resources, including brochures, infographics, user manuals, validation data, technical notes, and white papers. Easily filter by document type, application, research area, and products to find the specific information you need.
Filters
| Documents | Document type | Application | Research area | Product |
|---|---|---|---|---|
Data normalization and standardization This paper describes Olink®’s built-in QC system, NPX calculation and definition, and the different normalization methods we use. Registration required | ||||
Designing Non-Terminal Longitudinal Mouse Studies Registration required | ||||
Development and validation of customized PEA biomarker panels with clinical utility This describes how PEA can be applied to the development and validation of lower-plex assays that could help to translate protein signatures from discovery to clinical utility. Registration required | ||||
Discovering more with less Registration required | ||||
Empowering genomics with high-throughput proteomics Registration required | ||||
Ensuring quality with flexibility- Olink® Flex validation & verification This white paper transparently presents some of the results from our verification and validation tests carried out during the development of Olink® Flex. Registration required | ||||
Identification of potential biomarkers of prediabetes and diabetes using Olink Reveal Registration required | ||||
Insights into clinical applications of protein signatures Registration required | ||||
Insights into cytokine storm research with circulating biomarkers (long) Registration required | ||||
Insights into immuno-oncology research Registration required | ||||
Insights into pharmacokinetics and pharmacodynamics studies Registration required | ||||
Insights into Th cytokine profiling in disease research Registration required | ||||
Insights into the predictive value of blood IFN signature in cancer Registration required | ||||
Measuring protein biomarkers with Olink® - technical comparisons and orthogonal validation This white paper addresses how data from Olink® studies compares to other technologies. We present examples of comparisons ranging from single-plex ELISAs to high multiplex assays and also provide useful tips for comparisons between Olink® data and data from other technologies. Registration required | ||||
Multiple analysis of inflammatory proteins: a comparative study across multiple platforms This study compared the Olink® Target 48 Cytokine head-to-head with two commonly used commercial multiplex proteomics platforms, as well as to Olink® Explore 1536. Registration required | ||||
Multiple analysis of inflammatory proteins: a comparative study across multiple platforms - APPENDIX Additional comparative data from the study described in the original white paper. Registration required | ||||
Olink Target 48 Mouse Cytokine comprehensive product brochure Registration required | ||||
Olink White Paper What is a good biomarker Registration required | ||||
Olink® Reveal Chronic Lymphocytic Leukemia Case Study Case study on Chronic Lymphocytic Leukemia for Olink® Reveal Registration required | ||||
PEA- a high-multiplex immunoassay technology with qPCR or NGS readout A short overview of how the unique technology behind Olink®’s biomarker panels with NGS or qPCR readout works and how it overcomes the problems normally associated with multiplexed immunoassays. Registration required |